Collectively, these findings demonstrate that EFTUD2 contributes to the stabilization of c-MYC expression by preventing its ubiquitination, ultimately influencing the malignant biological phenotype of CRC cells, including their sensitivity to the 5-FU treatment. The gene discussed is EFTUD2; the disease is colorectal carcinoma.